Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID.

Bénédicte CaronPhilippe SeksikAnthony BuissonPauline WilsGuillaume SavoyeCarmen StefanescuDavid LaharieLucas GuilloVered AbitbolJoelle BonnetRomain AltweggLucine VuittonDriffa MoussataArnaud BourreilleAmélie BironCyrielle GillettaMathurin FumeryStephane NahonStéphane NanceyHouda CamaraLaurent Peyrin Biroulet

Published in: Therapeutic advances in gastroenterology (2024)

In this real-world setting, patients with IBD had a high level of satisfaction with adalimumab treatment, with some differences in terms of overall satisfaction and satisfaction with the injection device.

Keyphrases

rheumatoid arthritis
ulcerative colitis
juvenile idiopathic arthritis
case report
hidradenitis suppurativa
ultrasound guided
systemic lupus erythematosus
replacement therapy
smoking cessation